Best Blue Chip Stocks To Own For 2019


Stocks inched upward Friday after remarks by Federal Reserve Chair Janet Yellen pointed to a rate hike later this month.

The Dow and S&P 500 posted fractional gains. The blue chips barely finished higher on the day, up 3 points and staying above 21,000, ending at 21,005.71.

Climbing 0.2% was the Nasdaq composite, to 5870.75.

“At our meeting later this month, the committee will evaluate whether employment and inflation are continuing to evolve in line with our expectations, in which case a further adjustment of the federal funds rate would likely be appropriate,” Yellen said in a 1 p.m. ET speech at the Executives’ Club of Chicago.


While Yellen couched her remark in conditional terms that depend on economic data, she preceded it by citing a job market that has been “strengthening” and inflation that has been “rising toward our target” of 2% annually.

Best Blue Chip Stocks To Own For 2019: Officemax Incorporated(OMX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shivom (CURRENCY:OMX) traded 3.2% higher against the US dollar during the 24-hour period ending at 23:00 PM E.T. on September 13th. One Shivom token can currently be purchased for about $0.0069 or 0.00000105 BTC on popular exchanges including Kucoin, CoinBene, Coinsuper and DDEX. During the last week, Shivom has traded 3.3% lower against the US dollar. Shivom has a total market capitalization of $3.93 million and $74,531.00 worth of Shivom was traded on exchanges in the last day.

  • [By Logan Wallace]

    Shivom (CURRENCY:OMX) traded down 12.7% against the U.S. dollar during the 24-hour period ending at 13:00 PM E.T. on September 26th. Shivom has a market cap of $3.56 million and approximately $42,709.00 worth of Shivom was traded on exchanges in the last day. In the last seven days, Shivom has traded down 8.3% against the U.S. dollar. One Shivom token can now be purchased for $0.0062 or 0.00000095 BTC on popular cryptocurrency exchanges including CoinBene, Kucoin, Coinsuper and IDEX.

Best Blue Chip Stocks To Own For 2019: Restoration Hardware Holdings Inc.(RH)


Advisors’ Opinion:

  • [By Isaac Pino, CPA]

    On the surface, upscale furniture retailer RH (NYSE:RH) seems to be doing a lot of things right. The company — formerly known as Restoration Hardware — has leaned into the upscale market, thereby differentiating its products from the competition. Its inspired storefronts are a far cry from cookie-cutter shopping malls, and a membership-based business model makes it less reliant on blowout sales.

  • [By Motley Fool Staff]

    In this segment from the MarketFoolery podcast, Motley Fool Asset Management’s Bill Barker has the unusual opportunity to force host Chris Hill to admit he was flat wrong. Awhile back, when upscale furniture retailer RH (NYSE:RH) made a new loyalty program one of the centerpieces of its recovery plan, Hill found it utterly risible. The joke’s on him: The shift to a membership model, improved cost controls, and a well-executed e-commerce plan have turned the company around, and the shares are way up.

  • [By Dan Caplinger]

    Traditional retailers have struggled in recent years from the e-commerce revolution, and few niches of the retail industry have been able to escape the effects. For RH (NYSE:RH), formerly known as Restoration Hardware, 2016 was almost the kiss of death. High-end luxury customers proved vulnerable to plunging crude oil prices that devastated economic expansion in energy-rich regions of the country.

  • [By Motley Fool Staff]

    In this segment, he shares an email — and a scorecard — from a listener who took a bit of a leap of faith. At the beginning of 2017, he opened positions in the five biggest losers in the Rule Breaker universe for 2016: Restoration Hardware (NYSE:RH), Juno Therapeutics, FireEye (NASDAQ:FEYE), GoPro (NASDAQ:GPRO), and Celldex Therapeutics (NASDAQ:CLDX). True, the Fool doesn’t usually suggest adding to your losers, but as Arlo points out, they were still active recommendations, and he didn’t own any shares of them. So how’d those stocks do from there? Well, without spoiling it, let’s say he didn’t bat 1000 — but Foolish investors don’t have to.

Best Blue Chip Stocks To Own For 2019: Banco Bradesco Sa(BBDO)


Advisors’ Opinion:

  • [By Ethan Ryder]

    News articles about Banco Bradesco (NYSE:BBDO) have trended somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Banco Bradesco earned a news impact score of 0.19 on Accern’s scale. Accern also gave news stories about the bank an impact score of 46.8086143489448 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Best Blue Chip Stocks To Own For 2019: Theravance Biopharma, Inc.(TBPH)


Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Theravance Biopharma (TBPH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By WWW.GURUFOCUS.COM]

    For the details of Woodford Investment Management LLP’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Woodford+Investment+Management+LLP

    These are the top 5 holdings of Woodford Investment Management LLPProthena Corp PLC (PRTA) – 11,557,614 shares, 37.95% of the total portfolio. Shares added by 0.25%Alkermes PLC (ALKS) – 5,270,428 shares, 27.32% of the total portfolio. Shares reduced by 30.52%Theravance Biopharma Inc (TBPH) – 10,898,879 shares, 23.64% of the total portfolio. Shares added by 1.41%Biogen Inc (BIIB) – 279,564 shares, 6.85% of the total portfolio. Shares reduced by 24.56%Evofem Biosciences Inc (EVFM) – 7,465,538

  • [By Max Byerly]

    Theravance Biopharma Inc (NASDAQ:TBPH) has received an average recommendation of “Hold” from the nine research firms that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, two have given a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $41.33.

  • [By Ethan Ryder]

    Theravance Biopharma (NASDAQ: TBPH) and Synlogic (NASDAQ:SYBX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

  • [By Max Byerly]

    Theravance Biopharma (NASDAQ:TBPH) – Investment analysts at Cantor Fitzgerald issued their FY2019 earnings estimates for shares of Theravance Biopharma in a research note issued to investors on Tuesday, May 22nd. Cantor Fitzgerald analyst L. Chen anticipates that the biopharmaceutical company will earn ($3.74) per share for the year. Cantor Fitzgerald currently has a “Buy” rating and a $55.00 price target on the stock.

Best Blue Chip Stocks To Own For 2019: Nuveen North Carolina Premium Income Municipal Fund(NNC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Wells Fargo & Company MN increased its holdings in Nuveen North Carol Premium Incom Mun Fd (NYSE:NNC) by 29.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 289,655 shares of the financial services provider’s stock after purchasing an additional 66,507 shares during the quarter. Wells Fargo & Company MN’s holdings in Nuveen North Carol Premium Incom Mun Fd were worth $3,554,000 at the end of the most recent reporting period.